Commonwealth of Pennsylvania Public School Empls Retrmt SYS decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 195,680 shares of the healthcare conglomerate's stock after selling 5,339 shares during the quarter. UnitedHealth Group accounts for approximately 0.6% of Commonwealth of Pennsylvania Public School Empls Retrmt SYS's portfolio, making the stock its 26th largest position. Commonwealth of Pennsylvania Public School Empls Retrmt SYS's holdings in UnitedHealth Group were worth $98,987,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $32,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter worth approximately $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the stock. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $629.32.
Read Our Latest Stock Analysis on UnitedHealth Group
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is currently owned by corporate insiders.
UnitedHealth Group Trading Up 0.0 %
NYSE UNH traded up $0.09 during mid-day trading on Monday, reaching $516.94. 3,840,856 shares of the stock were exchanged, compared to its average volume of 4,087,243. The business's fifty day simple moving average is $509.71 and its 200 day simple moving average is $546.15. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $472.85 billion, a PE ratio of 33.35, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.